Four Key Facts About Trump’s New Tariffs, and a Town Hall Showdown
The Headlines
00:00
The Rise and Fall of Novo Nordisk and the Ozempic Craze
This chapter chronicles the meteoric rise and subsequent challenges faced by Novo Nordisk due to its weight-loss drug Ozempic. It examines the implications of increased demand, supply issues, and emerging competition, while also highlighting the ongoing interest in weight-loss medications among U.S. adults.
Transcript
Play full episode
